Vertex Pharmaceuticals Topples 12% On A Series Of First-Quarter SetbacksInvestors Business Daily • 05/06/25
Ichor Holdings Posts Weak Earnings, Joins Fabrinet, Vertex Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market SessionBenzinga • 05/06/25
Vertex Pharmaceuticals (VRTX) Misses Q1 Earnings and Revenue EstimatesZacks Investment Research • 05/05/25
Vertex misses quarterly results on weaker-than-expected demand for cystic fibrosis drugReuters • 05/05/25
Vertex Has Lost Some Sizzle Into Q1 Earnings - Can Alyftrek, Journavx Reignite The Momentum?Benzinga • 05/05/25
Vertex Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings CallBenzinga • 05/05/25
Vertex Pharmaceuticals (VRTX) Outperforms Broader Market: What You Need to KnowZacks Investment Research • 04/30/25
What Analyst Projections for Key Metrics Reveal About Vertex (VRTX) Q1 EarningsZacks Investment Research • 04/30/25